Raymond James & Associates Dario Health Corp. Transaction History

Raymond James & Associates

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$10.47 - $20.87 $261,373 - $520,998	-24,964 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$13.9 - $22.58 $2,780 - $4,516	200 Added 0.81%	24,964 $533,000
Q1 2021 May 14, 2021	BUY	$15.41 - $30.42 $381,613 - $753,320	24,764 New	24,764 $477,000

7.99M

104K

5.6K

Ticker DRIO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 23,295,000
Market Cap $18.6M
Description
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.